(Q37023860)

17 August 2017

1 reference

title

Defining the role of NMP22 in bladder cancer surveillance (English)

1 reference

17 August 2017

1 reference

Carvell T Nguyen

1

1 reference

17 August 2017

J Stephen Jones

series ordinal

2

1 reference

17 August 2017

publication date

4 December 2007

1 reference

17 August 2017

published in

World Journal of Urology

1 reference

17 August 2017

volume

26

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

51-58

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-007-0226-z

17 August 2017

exact match

0 references

cites work

Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis

1 reference

12 December 2020

Urine markers for bladder cancer surveillance: a systematic review

1 reference

12 December 2020

A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results

1 reference

12 December 2020

[NMP-22 test. Is it useful in the follow-up of patients with superficial bladder tumor?]

1 reference

12 December 2020

Prognostic indices in transitional cell carcinoma of the bladder

1 reference

12 December 2020

Usefulness of urinary NMP22 to detect tumor recurrence of superficial bladder cancer after transurethral resection

1 reference

12 December 2020

Evaluation of nuclear matrix protein 22 (NMP22) as a tumor marker in the detection of bladder cancer

1 reference

12 December 2020

Detection of bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Role of cytokeratins, nuclear matrix proteins, Lewis antigen and epidermal growth factor receptor in human bladder tumors.

1 reference

12 December 2020

NuMA: an unusually long coiled-coil related protein in the mammalian nucleus

1 reference

12 December 2020

The community-based morbidity of flexible cystoscopy

1 reference

12 December 2020

Identification of a nuclear protein matrix.

1 reference

12 December 2020

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

1 reference

12 December 2020

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Urinary level of nuclear matrix protein 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor

1 reference

12 December 2020

Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer

1 reference

12 December 2020

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

1 reference

12 December 2020

A fixed site of DNA replication in eucaryotic cells

1 reference

12 December 2020

Utilization of nuclear matrix proteins for cancer diagnosis

1 reference

12 December 2020

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

1 reference

12 December 2020

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

1 reference

12 December 2020

Nuclear matrix proteins in human colon cancer

1 reference

12 December 2020

Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

1 reference

12 December 2020

Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors

1 reference

12 December 2020

Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence

1 reference

12 December 2020

Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma

1 reference

12 December 2020

Urothelial cancer biomarkers for detection and surveillance

1 reference

12 December 2020

Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: experience on 137 patients

1 reference

12 December 2020

Nuclear matrix proteins in normal and breast cancer cells

1 reference

12 December 2020

Screening and monitoring for bladder cancer: refining the use of NMP22

1 reference

12 December 2020

Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder

1 reference

12 December 2020

Urinary NMP22 and renal cell carcinoma

1 reference

12 December 2020

Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer

1 reference

12 December 2020

Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract

1 reference

12 December 2020

Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment

1 reference

12 December 2020

NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer

1 reference

12 December 2020

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

12 December 2020

NMP 22, BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study

1 reference

12 December 2020

False-positive results of the NMP22 test due to hematuria

1 reference

12 December 2020

Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests

1 reference

12 December 2020

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

12 December 2020

NuMA is required for the proper completion of mitosis.

1 reference

12 December 2020

Risk stratification for bladder tumor recurrence, stage and grade by urinary nuclear matrix protein 22 and cytology

1 reference

12 December 2020

Clinical application of NMP22 and urinary cytology in patients with hematuria or a history of urothelial carcinoma

1 reference

12 December 2020

[Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group]

1 reference

12 December 2020

Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG

1 reference

12 December 2020

Economic evaluation of NMP22 in the management of bladder cancer

1 reference

12 December 2020

Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.

1 reference

12 December 2020

Tumor markers in the diagnosis of primary bladder cancer. A systematic review

1 reference

12 December 2020

The role of nuclear matrix protein 22 combined with bladder tumor antigen stat test in surveillance of recurring bladder cancer

1 reference

12 December 2020

Urinary nuclear matrix protein 22 (NMP22): a diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

1 reference

12 December 2020

Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder

1 reference

12 December 2020

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

1 reference

12 December 2020

10.1007/S00345-007-0226-Z

Identifiers

DOI

1 reference

17 August 2017

1 reference